|
1
|
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.
|
Lancet
|
2008
|
36.01
|
|
2
|
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.
|
N Engl J Med
|
2014
|
28.65
|
|
3
|
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
|
Arch Intern Med
|
2003
|
24.99
|
|
4
|
Estimates of world-wide distribution of child deaths from acute respiratory infections.
|
Lancet Infect Dis
|
2002
|
6.73
|
|
5
|
The potential impact of male circumcision on HIV in Sub-Saharan Africa.
|
PLoS Med
|
2006
|
6.53
|
|
6
|
Tuberculosis.
|
Lancet
|
2003
|
6.39
|
|
7
|
Drivers of tuberculosis epidemics: the role of risk factors and social determinants.
|
Soc Sci Med
|
2009
|
5.93
|
|
8
|
Global incidence of multidrug-resistant tuberculosis.
|
J Infect Dis
|
2006
|
5.42
|
|
9
|
The international Ebola emergency.
|
N Engl J Med
|
2014
|
5.35
|
|
10
|
Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years.
|
Trop Med Int Health
|
2003
|
4.29
|
|
11
|
Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy.
|
Lancet Infect Dis
|
2003
|
4.10
|
|
12
|
Reducing the global burden of tuberculosis: the contribution of improved diagnostics.
|
Nature
|
2006
|
3.72
|
|
13
|
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru.
|
Lancet
|
2002
|
3.67
|
|
14
|
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.
|
PLoS Med
|
2012
|
3.44
|
|
15
|
Alcohol use as a risk factor for tuberculosis - a systematic review.
|
BMC Public Health
|
2008
|
3.32
|
|
16
|
Diabetes and the risk of tuberculosis: a neglected threat to public health?
|
Chronic Illn
|
2007
|
3.31
|
|
17
|
Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners.
|
Am J Respir Crit Care Med
|
2004
|
3.26
|
|
18
|
West African Ebola epidemic after one year--slowing but not yet under control.
|
N Engl J Med
|
2014
|
2.96
|
|
19
|
Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
|
Science
|
2003
|
2.83
|
|
20
|
HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.
|
J Infect Dis
|
2006
|
2.82
|
|
21
|
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
|
Proc Natl Acad Sci U S A
|
2009
|
2.78
|
|
22
|
Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods.
|
PLoS Med
|
2011
|
2.74
|
|
23
|
Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
|
BMJ
|
2005
|
2.50
|
|
24
|
Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.
|
Clin Infect Dis
|
2003
|
2.49
|
|
25
|
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.
|
Lancet Infect Dis
|
2006
|
2.48
|
|
26
|
Tuberculosis control in the era of HIV.
|
Nat Rev Immunol
|
2005
|
2.40
|
|
27
|
A consistent log-linear relationship between tuberculosis incidence and body mass index.
|
Int J Epidemiol
|
2009
|
2.20
|
|
28
|
Ebola virus disease in the Democratic Republic of Congo.
|
N Engl J Med
|
2014
|
2.19
|
|
29
|
Ebola virus disease among children in West Africa.
|
N Engl J Med
|
2015
|
2.17
|
|
30
|
Tuberculosis epidemics driven by HIV: is prevention better than cure?
|
AIDS
|
2003
|
2.11
|
|
31
|
Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
|
BMC Public Health
|
2005
|
2.09
|
|
32
|
Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission.
|
J Infect Dis
|
2002
|
1.97
|
|
33
|
Spatial analysis of tuberculosis cases in migrants and permanent residents, Beijing, 2000-2006.
|
Emerg Infect Dis
|
2008
|
1.91
|
|
34
|
Evaluation of immigrant tuberculosis screening in industrialized countries.
|
Emerg Infect Dis
|
2012
|
1.81
|
|
35
|
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies?
|
PLoS Med
|
2012
|
1.76
|
|
36
|
Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.
|
BMC Infect Dis
|
2010
|
1.67
|
|
37
|
Ebola vaccine--an urgent international priority.
|
N Engl J Med
|
2014
|
1.66
|
|
38
|
Highly active antiretroviral treatment for the prevention of HIV transmission.
|
J Int AIDS Soc
|
2010
|
1.51
|
|
39
|
The development and impact of tuberculosis vaccines.
|
Cell
|
2006
|
1.50
|
|
40
|
Antiretroviral therapy for tuberculosis control in nine African countries.
|
Proc Natl Acad Sci U S A
|
2010
|
1.48
|
|
41
|
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.
|
PLoS One
|
2009
|
1.31
|
|
42
|
The impact of new tuberculosis diagnostics on transmission: why context matters.
|
Bull World Health Organ
|
2012
|
1.27
|
|
43
|
Controlling the last known cluster of Ebola virus disease - Liberia, January-February 2015.
|
MMWR Morb Mortal Wkly Rep
|
2015
|
1.22
|
|
44
|
Health in financial crises: economic recession and tuberculosis in Central and Eastern Europe.
|
J R Soc Interface
|
2010
|
1.19
|
|
45
|
Can DOTS control multidrug-resistant tuberculosis?
|
Lancet
|
2005
|
1.09
|
|
46
|
Ebola Virus Disease among Male and Female Persons in West Africa.
|
N Engl J Med
|
2016
|
1.08
|
|
47
|
Combining domestic and foreign investment to expand tuberculosis control in China.
|
PLoS Med
|
2010
|
1.07
|
|
48
|
Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism.
|
Immunogenetics
|
2003
|
1.05
|
|
49
|
Modeling the impact of immigration on the epidemiology of tuberculosis.
|
Theor Popul Biol
|
2007
|
1.02
|
|
50
|
Role of acute infection in HIV transmission.
|
Lancet
|
2011
|
0.98
|
|
51
|
After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.
|
N Engl J Med
|
2016
|
0.94
|
|
52
|
Mathematical models of the epidemiology and control of drug-resistant TB.
|
Expert Rev Respir Med
|
2009
|
0.94
|
|
53
|
The Global Drug Facility and its role in the market for tuberculosis drugs.
|
Lancet
|
2013
|
0.93
|
|
54
|
Epidemiology. The SARS wake-up call.
|
Science
|
2013
|
0.90
|
|
55
|
Financing tuberculosis control: the role of a global financial monitoring system.
|
Bull World Health Organ
|
2007
|
0.89
|
|
56
|
Drug-resistant tuberculosis in Zhejiang Province, China, 1999-2008.
|
Emerg Infect Dis
|
2012
|
0.89
|
|
57
|
Breaking a law: tuberculosis disobeys Styblo's rule.
|
Bull World Health Organ
|
2008
|
0.89
|
|
58
|
Monitoring global health: WHO has mandate and expertise.
|
BMJ
|
2005
|
0.86
|
|
59
|
Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China.
|
Am J Drug Alcohol Abuse
|
2010
|
0.82
|
|
60
|
Ebola virus disease in West Africa--the first 9 months.
|
N Engl J Med
|
2015
|
0.82
|
|
61
|
Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other.
|
Epidemics
|
2008
|
0.80
|
|
62
|
Public health. A National Tuberculosis Archive.
|
Science
|
2006
|
0.80
|
|
63
|
New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya.
|
Bull World Health Organ
|
2009
|
0.79
|
|
64
|
A booster for tuberculosis vaccines.
|
JAMA
|
2004
|
0.79
|
|
65
|
India's leading role in tuberculosis epidemiology & control.
|
Indian J Med Res
|
2006
|
0.78
|
|
66
|
Research for universal health coverage.
|
Sci Transl Med
|
2013
|
0.77
|
|
67
|
Practical preventive therapy for tuberculosis?
|
N Engl J Med
|
2011
|
0.75
|
|
68
|
The science of sustainability.
|
Science
|
2013
|
0.75
|
|
69
|
The science of social diseases.
|
Science
|
2005
|
0.75
|